Takegawa K, Mitsumori K, Onodera H, Shimo T, Takahashi M, Yasuhara K, Takahashi M
Eisei Shikenjo Hokoku. 1996(114):33-7.
In order to investigate whether goitrogens and liver enzyme-inducers modify the tumorigenesis in the liver or lung, 6-week old male F344 rats were given single subcutaneous injection of DHPN, and starting one week later received water containing goitrogens, namely sulfadimethoxine (SDM), propylthiouracil (PTU) and potassium thiocyanate (KSCN), or an enzyme-inducer, phenobarbital (PB), for 19 weeks ad libitum. Although the number of GST-P positive foci in the liver was significantly increased in the PB group as compared to the control group, there were no significant fluctuations in the SDM, PTU and PB groups. With respect to the lung, it is suggested that SDM, KSCN and PB may enhance the lung tumorigenesis, since the multiplicities of hyperplasias of alveolar epithelia were increased in groups treated with these compounds.
为了研究致甲状腺肿物质和肝酶诱导剂是否会改变肝脏或肺部的肿瘤发生情况,对6周龄的雄性F344大鼠进行皮下单次注射DHPN,一周后开始随意饮用含有致甲状腺肿物质(即磺胺二甲氧嘧啶(SDM)、丙硫氧嘧啶(PTU)和硫氰酸钾(KSCN))或酶诱导剂苯巴比妥(PB)的水,持续19周。尽管与对照组相比,PB组肝脏中谷胱甘肽S-转移酶P(GST-P)阳性灶的数量显著增加,但SDM、PTU和PB组均无明显波动。关于肺部,由于用这些化合物处理的组中肺泡上皮细胞增生的倍数增加,提示SDM、KSCN和PB可能会增强肺部肿瘤发生。